{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:47:06Z","timestamp":1772524026029,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02187-3","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T15:02:12Z","timestamp":1695999732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dysregulated ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis"],"prefix":"10.1007","volume":"40","author":[{"given":"Sen","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-9467","authenticated-orcid":false,"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"2187_CR1","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.18632\/aging.202502","volume":"13","author":"J Huang","year":"2021","unstructured":"Huang J, et al. Global incidence and mortality of breast cancer: a trend analysis. Aging (Albany NY). 2021;13:5748\u2013803. https:\/\/doi.org\/10.18632\/aging.202502.","journal-title":"Aging (Albany NY)"},{"key":"2187_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.012.","journal-title":"Semin Cancer Biol"},{"issue":"62","key":"2187_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1590\/1806-9282.62.08.755","volume":"1992","author":"DS Eugenio","year":"2016","unstructured":"Eugenio DS, et al. Breast cancer features in women under the age of 40 years. Rev Assoc Med Bras. 2016;1992(62):755\u201361. https:\/\/doi.org\/10.1590\/1806-9282.62.08.755.","journal-title":"Rev Assoc Med Bras"},{"key":"2187_CR4","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30:1194\u2013220. https:\/\/doi.org\/10.1093\/annonc\/mdz173.","journal-title":"Ann Oncol"},{"key":"2187_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/CH-16242","volume":"66","author":"W Tang","year":"2017","unstructured":"Tang W, et al. Digital breast tomosynthesis plus mammography, magnetic resonance imaging plus mammography and mammography alone: a comparison of diagnostic performance in symptomatic women. Clin Hemorheol Microcirc. 2017;66:105\u201316. https:\/\/doi.org\/10.3233\/CH-16242.","journal-title":"Clin Hemorheol Microcirc"},{"key":"2187_CR6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.bbcan.2013.06.001","volume":"211\u2013226","author":"CE Nunes-Xavier","year":"1836","unstructured":"Nunes-Xavier CE, Martin-Perez J, Elson A, Pulido R. Protein tyrosine phosphatases as novel targets in breast cancer therapy. Biochim Biophys Acta. 1836;211\u2013226:2013. https:\/\/doi.org\/10.1016\/j.bbcan.2013.06.001.","journal-title":"Biochim Biophys Acta"},{"key":"2187_CR7","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.2174\/1381612823666170616082125","volume":"23","author":"M Kim","year":"2017","unstructured":"Kim M, Baek M, Kim DJ. Protein tyrosine signaling and its potential therapeutic implications in carcinogenesis. Curr Pharm Des. 2017;23:4226\u201346. https:\/\/doi.org\/10.2174\/1381612823666170616082125.","journal-title":"Curr Pharm Des"},{"key":"2187_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.semcdb.2014.09.012","volume":"37","author":"V Dubreuil","year":"2015","unstructured":"Dubreuil V, Sap J, Harroch S. Protein tyrosine phosphatase regulation of stem and progenitor cell biology. Semin Cell Dev Biol. 2015;37:82\u20139. https:\/\/doi.org\/10.1016\/j.semcdb.2014.09.012.","journal-title":"Semin Cell Dev Biol"},{"key":"2187_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/bioinformatics\/btab561","volume":"38","author":"S Wang","year":"2022","unstructured":"Wang S, et al. UCSCXenaShiny: an R\/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics. 2022;38:527\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btab561.","journal-title":"Bioinformatics"},{"key":"2187_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649\u201358. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002.","journal-title":"Neoplasia"},{"key":"2187_CR11","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","journal-title":"Nucleic Acids Res"},{"key":"2187_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0974-7788.76794","volume":"1","author":"MK Goel","year":"2010","unstructured":"Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1:274\u20138. https:\/\/doi.org\/10.4103\/0974-7788.76794.","journal-title":"Int J Ayurveda Res"},{"key":"2187_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur V, et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10:277\u201388. https:\/\/doi.org\/10.2217\/epi-2017-0118.","journal-title":"Epigenomics"},{"key":"2187_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa162","author":"C Zhang","year":"2021","unstructured":"Zhang C, et al. SurvivalMeth: a web server to investigate the effect of DNA methylation-related functional elements on prognosis. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbaa162.","journal-title":"Brief Bioinform"},{"key":"2187_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","author":"J Gao","year":"2013","unstructured":"Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal."},{"key":"2187_CR16","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312. https:\/\/doi.org\/10.1093\/nar\/gkaa1074.","journal-title":"Nucleic Acids Res"},{"key":"2187_CR17","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537.","journal-title":"Nucleic Acids Res"},{"key":"2187_CR18","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.","journal-title":"Genome Biol"},{"key":"2187_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"key":"2187_CR20","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han H, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46:D380\u20136. https:\/\/doi.org\/10.1093\/nar\/gkx1013.","journal-title":"Nucleic Acids Res"},{"key":"2187_CR21","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"key":"2187_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40246-016-0062-6","volume":"10","author":"KA Gray","year":"2016","unstructured":"Gray KA, Seal RL, Tweedie S, Wright MW, Bruford EA. A review of the new HGNC gene family resource. Hum Genomics. 2016;10:6. https:\/\/doi.org\/10.1186\/s40246-016-0062-6.","journal-title":"Hum Genomics"},{"key":"2187_CR23","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1158\/0008-5472.CAN-18-3631","volume":"79","author":"T Ubhi","year":"2019","unstructured":"Ubhi T, Brown GW. Exploiting DNA replication stress for cancer treatment. Cancer Res. 2019;79:1730\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3631.","journal-title":"Cancer Res"},{"key":"2187_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10549-022-06673-6","volume":"195","author":"M Tang","year":"2022","unstructured":"Tang M, O\u2019Grady S, Crown J, Duffy MJ. MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975. Breast Cancer Res Treat. 2022;195:105\u201315. https:\/\/doi.org\/10.1007\/s10549-022-06673-6.","journal-title":"Breast Cancer Res Treat"},{"key":"2187_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-beta signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21:104. https:\/\/doi.org\/10.1186\/s12943-022-01569-x.","journal-title":"Mol Cancer"},{"key":"2187_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010173","author":"D Miricescu","year":"2020","unstructured":"Miricescu D, et al. PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010173.","journal-title":"Int J Mol Sci"},{"key":"2187_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-020-01315-7","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Zhao X, Yuan Y, Jing JJ. The expression patterns and the diagnostic\/prognostic roles of PTPN family members in digestive tract cancers. Cancer Cell Int. 2020;20:238. https:\/\/doi.org\/10.1186\/s12935-020-01315-7.","journal-title":"Cancer Cell Int"},{"key":"2187_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrm2039","volume":"7","author":"NK Tonks","year":"2006","unstructured":"Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006;7:833\u201346. https:\/\/doi.org\/10.1038\/nrm2039.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2187_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1566523220999200731002408","volume":"20","author":"R Sahu","year":"2020","unstructured":"Sahu R, Pattanayak SP. Strategic developments & future perspective on gene therapy for breast cancer: role of mTOR and Brk\/ PTK6 as molecular targets. Curr Gene Ther. 2020;20:237\u201358. https:\/\/doi.org\/10.2174\/1566523220999200731002408.","journal-title":"Curr Gene Ther"},{"key":"2187_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.breast.2021.12.007","volume":"61","author":"D Akdeniz","year":"2022","unstructured":"Akdeniz D, et al. Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: a nationwide cohort study. Breast. 2022;61:98\u2013107. https:\/\/doi.org\/10.1016\/j.breast.2021.12.007.","journal-title":"Breast"},{"key":"2187_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12935-019-0958-z","volume":"19","author":"Y Li","year":"2019","unstructured":"Li Y, et al. Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206. Cancer Cell Int. 2019;19:275. https:\/\/doi.org\/10.1186\/s12935-019-0958-z.","journal-title":"Cancer Cell Int"},{"key":"2187_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/febs.14724","volume":"286","author":"M Yu","year":"2019","unstructured":"Yu M, et al. PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p. FEBS J. 2019;286:1136\u201353. https:\/\/doi.org\/10.1111\/febs.14724.","journal-title":"FEBS J"},{"key":"2187_CR33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.20892\/j.issn.2095-3941.2020.0501","volume":"19","author":"Q Geng","year":"2021","unstructured":"Geng Q, Xian R, Yu Y, Chen F, Li R. SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer. Cancer Biol Med. 2021;19:468\u201385. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0501.","journal-title":"Cancer Biol Med"},{"key":"2187_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109361","volume":"118","author":"L Yu","year":"2019","unstructured":"Yu L, et al. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt\/beta-catenin signaling. Biomed Pharmacother. 2019;118: 109361. https:\/\/doi.org\/10.1016\/j.biopha.2019.109361.","journal-title":"Biomed Pharmacother"},{"key":"2187_CR35","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/cam4.772","volume":"5","author":"J Shen","year":"2016","unstructured":"Shen J, et al. Role of DUSP1\/MKP1 in tumorigenesis, tumor progression and therapy. Cancer Med. 2016;5:2061\u20138. https:\/\/doi.org\/10.1002\/cam4.772.","journal-title":"Cancer Med"},{"key":"2187_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3892\/mmr.2018.9682","volume":"19","author":"Z Li","year":"2019","unstructured":"Li Z, Xu W, Ren X, Xu J, Chen J. Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer. Mol Med Rep. 2019;19:205\u201312. https:\/\/doi.org\/10.3892\/mmr.2018.9682.","journal-title":"Mol Med Rep"},{"key":"2187_CR37","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1158\/0008-5472.CAN-09-4368","volume":"70","author":"M Glondu-Lassis","year":"2010","unstructured":"Glondu-Lassis M, et al. PTPL1\/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of SRC kinase. Cancer Res. 2010;70:5116\u201326. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4368.","journal-title":"Cancer Res"},{"key":"2187_CR38","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/ijc.23989","volume":"124","author":"F Revillion","year":"2009","unstructured":"Revillion F, et al. Expression of the putative tumor suppressor gene PTPN13\/PTPL1 is an independent prognostic marker for overall survival in breast cancer. Int J Cancer. 2009;124:638\u201343. https:\/\/doi.org\/10.1002\/ijc.23989.","journal-title":"Int J Cancer"},{"key":"2187_CR39","doi-asserted-by":"publisher","first-page":"39260","DOI":"10.1074\/jbc.M110.174706","volume":"285","author":"A Carlucci","year":"2010","unstructured":"Carlucci A, et al. PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells. J Biol Chem. 2010;285:39260\u201370. https:\/\/doi.org\/10.1074\/jbc.M110.174706.","journal-title":"J Biol Chem"},{"key":"2187_CR40","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ejhg.2011.37","volume":"19","author":"MC Jongmans","year":"2011","unstructured":"Jongmans MC, et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet. 2011;19:870\u20134. https:\/\/doi.org\/10.1038\/ejhg.2011.37.","journal-title":"Eur J Hum Genet"},{"key":"2187_CR41","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","volume":"64","author":"M Bentires-Alj","year":"2004","unstructured":"Bentires-Alj M, et al. Activating mutations of the noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 2004;64:8816\u201320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1923.","journal-title":"Cancer Res"},{"key":"2187_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","volume":"39","author":"LB Wang","year":"2021","unstructured":"Wang LB, et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell. 2021;39:509-528 e520. https:\/\/doi.org\/10.1016\/j.ccell.2021.01.006.","journal-title":"Cancer Cell"},{"key":"2187_CR43","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/jcmm.12618","volume":"19","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang F, Niu R. Functions of Shp2 in cancer. J Cell Mol Med. 2015;19:2075\u201383. https:\/\/doi.org\/10.1111\/jcmm.12618.","journal-title":"J Cell Mol Med"},{"key":"2187_CR44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.20892\/j.issn.2095-3941.2020.0056","volume":"17","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, et al. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K\/AKT\/GSK3beta signaling pathway. Cancer Biol Med. 2020;17:707\u201325. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0056.","journal-title":"Cancer Biol Med"},{"key":"2187_CR45","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/cr.2014.99","volume":"24","author":"HM Wang","year":"2014","unstructured":"Wang HM, et al. The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes. Cell Res. 2014;24:1067\u201390. https:\/\/doi.org\/10.1038\/cr.2014.99.","journal-title":"Cell Res"},{"key":"2187_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-12-394274-6.00002-9","volume":"117","author":"SA Saddoughi","year":"2013","unstructured":"Saddoughi SA, Ogretmen B. Diverse functions of ceramide in cancer cell death and proliferation. Adv Cancer Res. 2013;117:37\u201358. https:\/\/doi.org\/10.1016\/B978-0-12-394274-6.00002-9.","journal-title":"Adv Cancer Res"},{"key":"2187_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen B. Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. 2018;18:33\u201350. https:\/\/doi.org\/10.1038\/nrc.2017.96.","journal-title":"Nat Rev Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02187-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T06:25:56Z","timestamp":1698387956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02187-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02187-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by Ningxia Medical University General Hospital Scientific Research Ethics Committee (KYLL-2023-0440).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patients\/participants provided their written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable for that section.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"310"}}